Healthcare / Medical Care FacilitiesNSE
$274.05
+2.07 (+0.72%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 25% · confianza 25%
FCF escenarios
weak_data · normalized FCF $2.1B · quality 66.3/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
63/100
B
Piotroski
6/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$118.4B
P/E
39.9x
↑EV/EBITDA
21.9x
↑ROE
12.8%
↑Gross Margin
63.1%
↑Debt/Equity
0.18
↓TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2023–2026 · 3 años de histórico normalizado
Revenue CAGR
+10.3%
FCF CAGR
+29.4%
FCF margin
12.5%
FCF / Net income
0.81x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $16.79B · net income $2.58B · FCF $2.09B
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2026 | 2025 | 2024 | 2023 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $16.79B | $16.79B | $13.94B | $12.29B | $12.52B |
| Net Income | $2.58B | $2.58B | $2.02B | $1.53B | $2.20B |
| EBITDA | $4.76B | $4.76B | $4.03B | $3.38B | $4.05B |
| EPS | 6.87 | 6.87 | 4.67 | 3.55 | 5.09 |
| Gross Margin | 63.1% | 63.1% | 60.0% | 61.5% | 67.1% |
| Operating Margin | 22.7% | 22.7% | 22.5% | 21.9% | 29.7% |
| Net Margin | 15.4% | 15.4% | 14.5% | 12.5% | 17.5% |
| Balance Sheet | |||||
| Debt/Equity | 0.18 | 0.18 | 0.64 | 0.78 | 0.84 |
| Current Ratio | 2.06 | 2.06 | — | — | — |
| Cash Flow | |||||
| Free Cash Flow | $2.09B | $2.09B | $702.6M | $2.90B | $966.0M |
| Returns | |||||
| ROE | 12.8% | 12.8% | 18.9% | 17.4% | 32.0% |
| Valuation | |||||
| P/E | 39.89 | 39.89 | — | — | — |
| EV/EBITDA | 21.90 | 21.90 | — | — | — |
| P/B | 5.09 | 5.09 | — | — | — |
| Growth & Yield | |||||
| Revenue Growth | 20.5% | 20.5% | 13.4% | -1.9% | — |
| EPS Growth | 47.2% | 47.2% | 31.4% | -30.1% | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
3Y implied EPS CAGR
52.4%
EPS terminal req.
$24.32
Spread vs growth
-5.2%
5Y implied EPS CAGR
33.8%
EPS terminal req.
$29.42
Spread vs growth
13.4%
10Y implied EPS CAGR
21.3%
EPS terminal req.
$47.39
Spread vs growth
25.9%
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
+95.0%
Start / end P/E
31.7x → 42.0x
EPS bridge
4.67 → 6.87
Residual
+15.3%
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.